申请人:Takeda Chemical Industries, Ltd.
公开号:US05246948A1
公开(公告)日:1993-09-21
There is disclosed a pharmaceutical composition for providing antiinflammatory, antipyretic, analgesic, antiallergic, immunosuppressing or immunomodulating activity which comprises a pyridine derivative of the formula (I): ##STR1## wherein R is an optionally substituted pyridine ring, X is a oxygen atom or --S(O)n--, wherein n is 0, 1 or 2, A is a bivalent C.sub.1-15 hydrocarbon residue whose branched moiety may have a substituent, Y is an oxygen or sulfur atom, R.sub.3 is a hydrogen atom or an optionally substituted hydrocarbon residue, R.sub.4 is an optionally substituted hydrocarbon residue or an optionally substituted monocyclic or bicyclic heterocyclic group, R.sub.3 and R.sub.4 may be joined together with the carbamoyl group or the thiocarbamoyl group to which they are attached to form an optionally substituted heterocyclic group, or R.sub.3 or R.sub.4 may be independently attached to A to form a ring, or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutically acceptable carrier or diluent.
揭示了一种用于提供抗炎、退烧、镇痛、抗过敏、免疫抑制或免疫调节活性的药物组合物,其包括下式的吡啶衍生物(I):其中R是一个可选取代的吡啶环,X是一个氧原子或--S(O)n--,其中n为0、1或2,A是一种二价的C.sub.1-15烃残基,其支链可能有取代基,Y是氧或硫原子,R.sub.3是氢原子或一个可选取代的烃残基,R.sub.4是一个可选取代的烃残基或一个可选取代的单环或双环杂环基,R.sub.3和R.sub.4可以与它们附着的氨甲酰基或硫氨甲酰基结合在一起形成一个可选取代的杂环基,或者R.sub.3或R.sub.4可以独立地连接到A上形成一个环,或其药学上可接受的盐或溶剂,以及药学上可接受的载体或稀释剂。